Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
PMV Pharmaceuticals, Inc. (PMVP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2023 |
4
| Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Exercised 85,500 options to buy
@ $0.53, valued at
$45.3k
|
|
| 06/12/2023 |
4
| Stelzer Laurie (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 21,500 options to buy
@ $5.59, valued at
$120.2k
|
|
| 06/12/2023 |
4
| LEVINE ARNOLD J (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 21,500 options to buy
@ $5.59, valued at
$120.2k
|
|
| 06/12/2023 |
4
| Heyman Richard A. (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 21,500 options to buy
@ $5.59, valued at
$120.2k
|
|
| 06/12/2023 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 21,500 options to buy
@ $5.59, valued at
$120.2k
Gifted 21,500 options to buy
@ $5.59, valued at
$120.2k
Gifted 21,500 options to buy
@ $5.59, valued at
$120.2k
|
|
| 06/12/2023 |
4
| FLOWERS KIRSTEN (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 21,500 options to buy
@ $5.59, valued at
$120.2k
|
|
| 06/12/2023 |
4
| BAUM CHARLES M (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 21,500 options to buy
@ $5.59, valued at
$120.2k
|
|
| 05/15/2023 |
4
| Jalota Deepika (Chief Development Officer) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $5.7, valued at
$712.5k
|
|
| 05/15/2023 |
4
| Alland Leila (Chief Medical Officer) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $5.7, valued at
$570k
|
|
| 05/15/2023 |
4
| Kung Winston (COO, CFO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $5.7, valued at
$855k
|
|
| 05/15/2023 |
4
| Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 330,000 options to buy
@ $5.7, valued at
$1.9M
|
|
| 01/30/2023 |
4
| Kung Winston (COO, CFO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Gifted 2,560 shares
@ $0 |
|
| 11/08/2022 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 39,000 options to buy
@ $11.28, valued at
$439.9k
Gifted 39,000 options to buy
@ $11.28, valued at
$439.9k
Gifted 39,000 options to buy
@ $11.28, valued at
$439.9k
|
|
| 09/13/2022 |
4
| Jalota Deepika (SVP, Regulatory Affairs and QA) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 34,050 shares
@ $0 |
|
| 09/13/2022 |
4
| Alland Leila (Chief Medical Officer) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 52,200 shares
@ $0 |
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2022 |
4
| Kung Winston (COO, CFO) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Exercised 4,000 options to buy
@ $3.22, valued at
$12.9k
|
|
| 03/31/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Sold 365,000 shares
@ $21.52, valued at
$7.9M
Sold 75,000 shares
@ $22.39, valued at
$1.7M
Sold 34,500 shares
@ $21.17, valued at
$730.4k
|
|
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Jalota Deepika (SVP, Regulatory Affairs and QA) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 68,100 options to buy
@ $16.29, valued at
$1.1M
|
|
| 02/28/2022 |
4
| Alland Leila (Chief Medical Officer) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 104,400 options to buy
@ $16.29, valued at
$1.7M
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2022 |
4
| FLOWERS KIRSTEN (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Exercised 32,677 options to buy
@ $19.06, valued at
$622.8k
|
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/08/2021 |
4
| Schroeder Thilo (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Sold 800 shares
@ $30.15, valued at
$24.1k
|
|
| 10/04/2021 |
4
| Schroeder Thilo (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Sold 2,978 shares
@ $30.03, valued at
$89.4k
Sold 11,541 shares
@ $30.1, valued at
$347.4k
Sold 100 shares
@ $30.08, valued at
$3k
|
|
|
|
|